Sponsored Links: Prescription Drug Addiction     July/August 2006 Safety Biomarkers Toxicology’s Holy Grail. By Pete Mitchell and Malorye A. Branca Related Coverage Toxicogenomics Gaining Ground By Nina Flanagan Additional Online Content FDA Tackles Drug Toxicity By Pete Mitchell Tailoring Breast Cancer Treatment Prognostic testing turning into hotbed of competition. Waiting to Inhale First airborne insulin hitting market. Deals Bring Value to Biotech Private-equity deals spark welcome trend in asset-rich industry. OUTLOOK: Ernst & Young Says Biotech Looks Poised for Maturity Drugmakers: Optimized for Failure? By Nat Goodman Pharma Urged to Register Early Trials WHO proposal may or may not help industry, patients. HDAC Inhibitors Surge Into Clinic First market is small, but opportunities abound RNAi Keeps Science on Its Toes The honeymoon is over, but big rewards are closer. TECH BRIEF: Expression Arrest Lentiviral shRNAmir: Mammalian RNAi Comes of Age TECH BRIEF: Single-Cell Genetics by siRNA Ablation and Mutant Rescue: Pitfalls and Prospects Thermo/Fisher’s Mega Footprint Merger will likely reshape tool sectors of life, lab, and health sciences. DEALMAKERS: Major Pharma, Biotech, and Related Agreements Editors Note - Do More Trials and Better Science Equal Success? New Products Email this page to a friend

Home | Contact Us | Subscribe | Privacy Policy THE CHI NETWORK Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |  Digital Healthcare & Productivity | Life Sciences Conference + Expo  | Molecular Medicine Tri-Conference | PEGSummit | PepTalk | PharmaWeek |  World Pharmaceutical Congress © 2006 Cambridge Healthtech Institute. All rights reserved. Reproduction in whole or in part is prohibited. Please send any technical comments or questions to our webmaster.